Iridex Corp
IRIX- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001006045
In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Iridex Corp changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 28 | 26 | −2 |
| Shares | 3.53M | 3.60M | +65.8K (+1.9%) |
| Value | $8.51M | $7.23M | −$1.28M (−15.0%) |
New holders (2)
Institutions that held Iridex Corp at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 9,233 | $18.6K | 0.00% |
| Bank of America Corp | 15 | $30 | 0.00% |
Sold out (4)
Institutions that held Iridex Corp at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Punch & Associates Investment Management, Inc. | 163,466 | $394.0K |
| UBS Group AG | 1,500 | $4.00K |
| Royal Bank of Canada | 41 | $0 |
| Tower Research Capital LLC (TRC) | 36 | $0 |